A Study, Comparing a Dose-Titration Regimen of Fulvestrant With the Approved Dosing Regimen in Postmenopausal Patients With Hormone-Responsive Advanced Breast Cancer (ABC) (FIDeS)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2009 by Regina Elena Cancer Institute. Recruitment status was Recruiting
Study NCT00927511
Information provided by Regina Elena Cancer Institute
First Received on June 24, 2009.
Last Updated on July 21, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
